These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. An animal model of intra-abdominal sepsis. Bartlett JG; Gorbach SL Scand J Infect Dis Suppl; 1979; (19):26-9. PubMed ID: 111347 [No Abstract] [Full Text] [Related]
7. Reciprocal synergy between Escherichia coli and Bacteroides fragilis in an intra-abdominal infection model. Rotstein OD; Kao J; Houston K J Med Microbiol; 1989 Aug; 29(4):269-76. PubMed ID: 2668529 [TBL] [Abstract][Full Text] [Related]
9. A peritonitis model with low mortality and persisting intra-abdominal abscesses. Buyne OR; Bleichrodt RP; Verweij PE; Groenewoud HM; van Goor H; Hendriks T Int J Exp Pathol; 2006 Oct; 87(5):361-8. PubMed ID: 16965563 [TBL] [Abstract][Full Text] [Related]
10. Aerobic and anaerobic bacteriology of perirectal abscess in children. Brook I; Martin WJ Pediatrics; 1980 Aug; 66(2):282-4. PubMed ID: 7402814 [TBL] [Abstract][Full Text] [Related]
11. Anaerobes in human biliary tracts. England DM; Rosenblatt JE J Clin Microbiol; 1977 Nov; 6(5):494-8. PubMed ID: 200634 [TBL] [Abstract][Full Text] [Related]
12. A 12 year study of aerobic and anaerobic bacteria in intra-abdominal and postsurgical abdominal wound infections. Brook I Surg Gynecol Obstet; 1989 Nov; 169(5):387-92. PubMed ID: 2683149 [TBL] [Abstract][Full Text] [Related]
13. Polysaccharide-mediated protection against abscess formation in experimental intra-abdominal sepsis. Tzianabos AO; Kasper DL; Cisneros RL; Smith RS; Onderdonk AB J Clin Invest; 1995 Dec; 96(6):2727-31. PubMed ID: 8675640 [TBL] [Abstract][Full Text] [Related]
14. Cutaneous abscesses. Anaerobic and aerobic bacteriology and outpatient management. Meislin HW; Lerner SA; Graves MH; McGehee MD; Kocka FE; Morello JA; Rosen P Ann Intern Med; 1977 Aug; 87(2):145-9. PubMed ID: 196534 [TBL] [Abstract][Full Text] [Related]
15. Anaerobic bacteriology. Isolation and identification of Bacteroides and Fusobacterium from human sources. Cadogan-Cowper G; Wilkinson RG Aust J Exp Biol Med Sci; 1974 Dec; 52(6):897-908. PubMed ID: 4618471 [No Abstract] [Full Text] [Related]
16. Effect of metronidazole on Escherichia coli in the presence of Bacteroides fragilis: an investigation in mice. Reznikov M; McDonald PJ Chemotherapy; 1983; 29(3):225-9. PubMed ID: 6347547 [TBL] [Abstract][Full Text] [Related]
17. Fibrin in peritonitis. IV. Synergistic intraperitoneal infection caused by Escherichia coli and Bacteroides fragilis within fibrin clots. Dunn DL; Rotstein OD; Simmons RL Arch Surg; 1984 Feb; 119(2):139-44. PubMed ID: 6365029 [TBL] [Abstract][Full Text] [Related]
18. Manipulation of the size and clone of an intra-abdominal abscess in rats. Nakatani T; Sato T; Trump BF; Siegel JH; Kobayashi K Res Exp Med (Berl); 1996; 196(2):117-26. PubMed ID: 8739801 [TBL] [Abstract][Full Text] [Related]
19. A standardised and reproducible model of intraabdominal infection and abscess formation in rats. Bosscha K; Nieuwenhuijs VB; Gooszen AW; van Duijvenbode-Beumer H; Visser MR; Verweij WR; Akkermans LM Eur J Surg; 2000 Dec; 166(12):963-7. PubMed ID: 11152259 [TBL] [Abstract][Full Text] [Related]
20. In-vivo bactericidal activity of Sch 34343 in Bacteroides fragilis abscesses and in Bacteroides fragilis-Escherichia coli abscesses. Wells CL; Arland LA; Simmons RL; Rotstein OD J Antimicrob Chemother; 1985 Jun; 15 Suppl C():199-206. PubMed ID: 3897172 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]